Salt Lake City, Utah — According to state and local development sources, Denali Therapeutics plans to invest $3,649,055.00 to build out new space in Salt Lake City. The company plans to occupy the new space at 5835 W Amelia Earhart Suite 7 in Salt Lake City, on or about March 1, 2024. According to the company website Denali Therapeutics is dedicated to defeating neurodegenerative diseases by breaking through historical barriers in scientific research and clinical development in order to deliver safe and effective medicines to patients and families. Our scientific approach is based on three core principles: rigorous assessment of genetic targets, engineering brain delivery, and using biomarkers to guide development. Our team thrives in a work environment that is scientifically driven, impact-focused, supportive, and collaborative. Our ability to have a positive impact on peoples lives is directly related to the trust we have in each other and our ability to unify our diverse backgrounds and experience behind our purpose to defeat degeneration.

To learn more about Denali Therapeutics, visit http://www.denalitherapeutics.com/

Company Contact:
Ryan Watts, Chief Executive Officer
https://www.linkedin.com/in/ryan-watts-0385b9b0/
650-866-8548

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.